Insider Transactions in Q3 2022 at Verve Therapeutics, Inc. (VERV)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
60,000
-50.81%
|
$2,100,000
$35.4 P/Share
|
|
Sep 23
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+44.53%
|
$60,000
$1.48 P/Share
|
|
Aug 25
2022
|
Andrew D. Ashe |
BUY
Exercise of conversion of derivative security
|
Direct |
95,787
+11.44%
|
$95,787
$1.91 P/Share
|
|
Aug 10
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-13.59%
|
$1,450,000
$29.9 P/Share
|
|
Aug 10
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.97%
|
$50,000
$1.39 P/Share
|
|
Jul 20
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-75.11%
|
$680,000
$34.9 P/Share
|
|
Jul 20
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+42.89%
|
$20,000
$1.39 P/Share
|
|
Jul 19
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-13.59%
|
$1,450,000
$29.9 P/Share
|
|
Jul 19
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.97%
|
$50,000
$1.39 P/Share
|
|
Jul 13
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-60.14%
|
$240,000
$24.9 P/Share
|
|
Jul 13
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.55%
|
$10,000
$1.48 P/Share
|
|
Jul 12
2022
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
163,000
-11.79%
|
$3,423,000
$21.01 P/Share
|
|
Jul 07
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
160,000
+39.9%
|
-
|
|
Jul 07
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
160,000
-33.48%
|
-
|
|
Jul 01
2022
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
38,775
-4.77%
|
$581,625
$15.66 P/Share
|